Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.
The anthracyclines, such as doxorubicin (DXR), are potent anti-cancer drugs but they are limited by their clinical toxicity. The mechanisms involved remain poorly understood partly because of the difficulty in determining sub-cellular drug localisation. Using a novel method utilising the fluorescent...
Hauptverfasser: | Ashley, N, Poulton, J |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2009
|
Ähnliche Einträge
Ähnliche Einträge
-
Targeting DNA with Anthracyclines: The Importance of the Sugar Moiety
von: Waldemar Priebe
Veröffentlicht: (2000-03-01) -
Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
von: Ashley, N, et al.
Veröffentlicht: (2009) -
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
von: Junqi Huang, et al.
Veröffentlicht: (2022-02-01) -
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
von: Craig Davison, et al.
Veröffentlicht: (2021-04-01) -
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
von: Alessandra Murabito, et al.
Veröffentlicht: (2020-03-01)